Modeling Capabilities

Digital Twins

Patient-specific virtual models that integrate multi-omic data to simulate individual physiology and predict personalized drug responses.

  • Individual patient representation
  • Real-time state synchronization
  • Treatment simulation

PBPK Modeling

Physiologically-based pharmacokinetic models predicting drug absorption, distribution, metabolism, and excretion across tissues.

  • Multi-compartment physiology
  • Drug-drug interactions
  • Population variability

Machine Learning

Deep learning and ensemble methods trained on clinical outcomes to predict treatment efficacy and adverse events.

  • Transformer architectures
  • Graph neural networks
  • Ensemble predictions

Systems Biology

Network-based models capturing pathway interactions, feedback loops, and emergent system behaviors.

  • Pathway modeling
  • Network perturbation
  • Multi-scale integration

Neural Architecture

100B+
Model Parameters
10M+
Training Samples
92%
Prediction Accuracy
<1s
Inference Time

Model Integration Pipeline

Multi-Modal Fusion

Combines genomic, proteomic, imaging, and clinical data into unified patient embeddings.

Temporal Modeling

Captures disease progression and treatment dynamics over time using attention mechanisms.

Uncertainty Quantification

Bayesian approaches provide confidence intervals and identify when predictions are unreliable.

Prediction Capabilities

Drug Response

Predict individual patient response to specific drugs including efficacy likelihood and optimal dosing.

Toxicity Risk

Identify patients at elevated risk for adverse drug reactions based on genetic and phenotypic factors.

Disease Progression

Model disease trajectory and identify inflection points for therapeutic intervention.

Biomarker Discovery

Identify novel biomarkers predictive of treatment response through feature importance analysis.